Perceptive Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Perceptive Advisors's IONS Position: Q3 2026 in Review
Perceptive Advisors sold out of Ionis Pharmaceuticals (IONS) in Q3 2026, closing a stake of 566,000 shares — an estimated $44.9M sold.
Perceptive Advisors first reported a position in IONS in Q3 2013 and held it in 3 quarters. The position peaked at $44.9M in Q2 2026. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Perceptive Advisors reported no remaining Ionis Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Perceptive Advisors sold 566,000 Ionis Pharmaceuticals shares in Q3 2026, an estimated $44.9M.
- Perceptive Advisors first reported a position in Ionis Pharmaceuticals in Q3 2013 and held it in 3 quarters.
- Perceptive Advisors's Ionis Pharmaceuticals position peaked at $44.9M in Q2 2026.
- 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Perceptive Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.